Search Within

Zhigang Zhang

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (23)
  3. Research Letter (3)
  4. Review (1)
Groups
  1. Biostatistics Service (58)
  2. Epidemiology and Biostatistics (58)
  3. Population Sciences Research Program (58)
  4. Radiation Oncology, Department of (46)
  5. Survivorship Research (37)
  6. Department of Medicine (36)

More Groups

People
  1. Erin Gillespie (31)
  2. Simon Powell (29)
  3. Atif Khan (24)
  4. Beryl McCormick (22)
  5. Jessica Flynn (20)
  6. Lior Braunstein (20)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (10)
  6. 2020 (7)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (22)
  2. Advances in Radiation Oncology (7)
  3. Journal of Clinical Oncology (5)
  4. Blood (4)
  5. Annals of Surgical Oncology (1)
  6. Asia-Pacific Journal of Oncology Nursing (1)

More Publications

Publishers
  1. Elsevier Inc. (30)
  2. American Society of Clinical Oncology (8)
  3. American Society of Hematology (5)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons (2)
  6. American Medical Association (1)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast radiotherapy among ATM-mutation carriers
    Meeting Abstract

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; Cahlon, O.; McCormick, B.; Robson, M. E.; Powell, S. N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Patterns and disparities of ablative radiation therapy use in patients with metastatic cancer: A study of the National Cancer Database
    Meeting Abstract

    Koenig, J. L.; Shi, W.; Hannum, M.; Yang, T. J.; Gillespie, E. F.; Zhang, Z.; Pollom, E.; Tsai, C. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Breast cancer in patients age <= 35 years: Overall survival, disease-free survival, secondary malignancies, and contralateral breast cancers rates across 10 years of follow-up
    Meeting Abstract

    Khan, A. J.; Billena, C.; Wilgucki, M.; Flynn, J.; Modlin, L. A.; Tadros, A. B.; Razavi, P.; Braunstein, L. Z.; Gillespie, E. F.; Cahlon, O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Breast-conserving therapy for DCIS: Local recurrence following boost radiotherapy
    Meeting Abstract

    Max, D.; Flynn, J.; Zhang, Z.; Mueller, B. A.; Gillespie, E. F.; Khan, A. J.; Cahlon, O.; Powell, S. N.; McCormick, B.; Braunstein, L. Z.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Daily fractionation of external beam accelerated partial breast irradiation to 40 Gy is well tolerated and locally effective
    Journal Article

    Braunstein, L. Z.; Thor, M.; Flynn, J.; Cost, Z.; Wilgucki, M.; Rosenbaum, S.; Zhang, Z.; Gillespie, E.; McCormick, B.; Khan, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
    Journal Article

    Kumar, A.; Vardhana, S.; Moskowitz, A. J.; Porcu, P.; Dogan, A.; Dubovsky, J. A.; Matasar, M. J.; Zhang, Z.; Younes, A.; Horwitz, S. M.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • HEART (Heart Evaluation After Radiation Therapy): Novel detection of cardiotoxicity in breast cancer patients
    Meeting Abstract

    Yang, J. C.; Gelblum, D.; Jones, L.; Yu, A.; Zhigang, Z.; Cahlon, O.; McCormick, B.; Powell, S. N.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer
    Journal Article

    Goodman, K. A.; Julie, D.; Cercek, A.; Cambridge, L.; Woo, K. M.; Zhang, Z.; Wu, A. J.; Reidy, D. L.; Segal, N. H.; Stadler, Z. K.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save